DERMATITIS
Clinical trials for DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new DERMATITIS trials appear
Sign up with your email to follow new studies for DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World study tracks eczema Drug's performance outside the lab
Disease control Recruiting nowThis study follows 200 people aged 12 and older with moderate-to-severe eczema who are starting a new prescription of abrocitinib. Researchers will track how well the drug controls symptoms like itching and rash over 12 months in real-world settings. The goal is to see if the imp…
Matched conditions: DERMATITIS
Sponsor: Pfizer • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Hypnosis for eczema in kids: a soothing solution?
Symptom relief Recruiting nowThis study tests if hypnosis can help children aged 8 to 17 with eczema (atopic dermatitis) manage itching, stress, and skin discomfort. Researchers will enroll 32 kids to see if a hypnosis program is practical and helpful. The goal is to reduce symptoms and improve quality of li…
Matched conditions: DERMATITIS
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Symptom relief
Last updated May 17, 2026 04:11 UTC
-
Eczema study reveals how treatments reshape Skin's bacterial landscape
Knowledge-focused Recruiting nowThis study looks at how treatments for eczema (atopic dermatitis) change the types and amounts of bacteria on the skin. Researchers will compare skin samples from people with eczema and healthy volunteers over one year. The goal is to understand how treatments affect the skin's m…
Matched conditions: DERMATITIS
Phase: PHASE2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated May 17, 2026 04:27 UTC
-
New skin drug SHR-1894 enters first human safety trial
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called SHR-1894 in 40 healthy adults to see if it is safe and how the body processes it. Participants receive a single injection and are monitored for side effects and drug levels. The goal is to gather safety information, not to treat any …
Matched conditions: DERMATITIS
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC